State Street’s Vanda Pharmaceuticals VNDA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$5.97M Buy
1,265,847
+13,288
+1% +$62.7K ﹤0.01% 2855
2025
Q1
$5.75M Buy
1,252,559
+68,696
+6% +$315K ﹤0.01% 2819
2024
Q4
$5.67M Buy
1,183,863
+18,681
+2% +$89.5K ﹤0.01% 2911
2024
Q3
$5.46M Sell
1,165,182
-46,127
-4% -$216K ﹤0.01% 2923
2024
Q2
$6.84M Buy
1,211,309
+8,014
+0.7% +$45.3K ﹤0.01% 2773
2024
Q1
$4.95M Sell
1,203,295
-24,801
-2% -$102K ﹤0.01% 2930
2023
Q4
$5.18M Sell
1,228,096
-75,685
-6% -$319K ﹤0.01% 2930
2023
Q3
$5.63M Sell
1,303,781
-2,776,855
-68% -$12M ﹤0.01% 2866
2023
Q2
$26.9M Sell
4,080,636
-471,276
-10% -$3.11M ﹤0.01% 2057
2023
Q1
$30.9M Buy
4,551,912
+824,114
+22% +$5.6M ﹤0.01% 1952
2022
Q4
$27.5M Buy
3,727,798
+42,447
+1% +$314K ﹤0.01% 2015
2022
Q3
$36.4M Sell
3,685,351
-30,574
-0.8% -$302K ﹤0.01% 1820
2022
Q2
$40.5M Sell
3,715,925
-347,373
-9% -$3.79M ﹤0.01% 1790
2022
Q1
$46M Buy
4,063,298
+735,865
+22% +$8.32M ﹤0.01% 1819
2021
Q4
$52.2M Sell
3,327,433
-70,609
-2% -$1.11M ﹤0.01% 1776
2021
Q3
$58.2M Buy
3,398,042
+236,533
+7% +$4.05M ﹤0.01% 1702
2021
Q2
$68M Sell
3,161,509
-150,830
-5% -$3.24M ﹤0.01% 1614
2021
Q1
$49.8M Buy
3,312,339
+108,435
+3% +$1.63M ﹤0.01% 1752
2020
Q4
$42.1M Sell
3,203,904
-181,430
-5% -$2.38M ﹤0.01% 1745
2020
Q3
$32.7M Sell
3,385,334
-293,278
-8% -$2.83M ﹤0.01% 1742
2020
Q2
$42.1M Buy
3,678,612
+842,696
+30% +$9.64M ﹤0.01% 1561
2020
Q1
$29.4M Buy
2,835,916
+301,896
+12% +$3.13M ﹤0.01% 1587
2019
Q4
$41.6M Sell
2,534,020
-331,817
-12% -$5.45M ﹤0.01% 1638
2019
Q3
$38.1M Sell
2,865,837
-134,979
-4% -$1.79M ﹤0.01% 1634
2019
Q2
$42.3M Sell
3,000,816
-671,993
-18% -$9.47M ﹤0.01% 1590
2019
Q1
$67.6M Buy
3,672,809
+1,200,854
+49% +$22.1M 0.01% 1267
2018
Q4
$64.6M Sell
2,471,955
-59,786
-2% -$1.56M 0.01% 1195
2018
Q3
$58.1M Buy
2,531,741
+358,730
+17% +$8.23M ﹤0.01% 1431
2018
Q2
$41.4M Buy
2,173,011
+288,921
+15% +$5.5M ﹤0.01% 1601
2018
Q1
$31.7M Sell
1,884,090
-251,137
-12% -$4.23M ﹤0.01% 1735
2017
Q4
$32.5M Buy
2,135,227
+486,595
+30% +$7.4M ﹤0.01% 1734
2017
Q3
$29.5M Buy
1,648,632
+30,147
+2% +$540K ﹤0.01% 1737
2017
Q2
$26.4M Buy
1,618,485
+46,299
+3% +$755K ﹤0.01% 1803
2017
Q1
$22M Sell
1,572,186
-179,419
-10% -$2.51M ﹤0.01% 1874
2016
Q4
$27.9M Buy
1,751,605
+374,095
+27% +$5.97M ﹤0.01% 1655
2016
Q3
$22.9M Buy
1,377,510
+92,456
+7% +$1.54M ﹤0.01% 1692
2016
Q2
$14.4M Sell
1,285,054
-203,313
-14% -$2.28M ﹤0.01% 1984
2016
Q1
$12.4M Sell
1,488,367
-200,399
-12% -$1.68M ﹤0.01% 2043
2015
Q4
$15.7M Sell
1,688,766
-799,413
-32% -$7.44M ﹤0.01% 1890
2015
Q3
$28.1M Sell
2,488,179
-81,438
-3% -$919K ﹤0.01% 1516
2015
Q2
$32.6M Sell
2,569,617
-115,978
-4% -$1.47M ﹤0.01% 1531
2015
Q1
$25M Buy
2,685,595
+808,011
+43% +$7.51M ﹤0.01% 1696
2014
Q4
$26.9M Buy
1,877,584
+65,250
+4% +$934K ﹤0.01% 1582
2014
Q3
$18.8M Buy
1,812,334
+260,416
+17% +$2.7M ﹤0.01% 1789
2014
Q2
$25.1M Sell
1,551,918
-2,512
-0.2% -$40.6K ﹤0.01% 1656
2014
Q1
$25.3M Buy
1,554,430
+988,158
+175% +$16.1M ﹤0.01% 1599
2013
Q4
$7.03M Buy
566,272
+41,440
+8% +$514K ﹤0.01% 2376
2013
Q3
$5.76M Buy
524,832
+14,314
+3% +$157K ﹤0.01% 2454
2013
Q2
$4.13M Buy
+510,518
New +$4.13M ﹤0.01% 2576